Daily Cardiology Academy
Daily cardiology
to enjoy learning and progressing in cardiometabolic practice
Author
Daily Cardiology Academy
Category
Podcast website
Latest episode
Jul 10, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention 30.01.2024 6:07
Impact: SAPT 1 year after PCI
Impact: Validity of a speech analysis app for the prediction of HF worseningImpact: Speech analysis 30.01.2024 3:14
Impact: Speech analysis to predict HF events, Cordio HearO
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy 30.01.2024 6:56
Case Discussion 109 Answer: GI protection in SAPT
Case Discussion 110 Answer: Tapering off medical therapy in acute idiopathic pericarditis 30.01.2024 4:26
Case Discussion 110 Answer: Medical therapy in acute pericarditis
Hypertension and Hyperlipidemia Academy, No. 15 - Part 2 19.01.2024 1:12:01
15th H&H Academy
Hypertension and Hyperlipidemia Academy, No. 15 - Part 1 18.01.2024 1:14:54
15th H&H Academy
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros 10.01.2024 33:48
Diabeat 9th session, case based discussion
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons 10.01.2024 20:28
Diabeat 9th session, case based discussion
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion 02.01.2024 1:43:27
Diabeat 9th session, case based discussion
Hypertension and Hyperlipidemia Academy, No. 14 - Part 2 01.01.2024 58:01
14th H&H Academy
Hypertension and Hyperlipidemia Academy, No. 14 - Part 1 01.01.2024 1:31:47
14th H&H Academy
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis 11.12.2023 9:19
Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
H&H Academy in 7-minutes, Episode 1 11.12.2023 7:18
H&H in 7 minutes, 1
AHA23 Congress Coverage: A Placebo-Controlled Trial of PCI for Stable Angina: The ORBITA-2 trial 04.12.2023 9:08
AHA23 Congress Coverage: PCI for Stable Angina (ORBITA-2 Trial)
Case Discussion 103 Answer: Approach to the management of Ascending Aorta Dilation 04.12.2023 12:43
Case Discussion 103 Answer: Ascending Aorta Dilation
AHA23 Congress Coverage: Impact of Female Sex on Cardiogenic Shock Outcomes 04.12.2023 2:20
AHA23 Congress Coverage: Cardiogenic Shock in Women
AHA23 Congress Coverage: Lepodisiran Dose-Ascending Trial 04.12.2023 5:05
AHA23 Congress Coverage: Lepodisiran Dose-Ascending Trial
AHA23 Congress Coverage: Daily Marijuana Use is Associated With HF: “All of Us” Research Program 03.12.2023 3:01
AHA23 Congress Coverage: Daily Marijuana and HF ("All of Us Research Program")
AHA23 Congress Coverage: Long-Term BP Control After Hypertensive Pregnancy: The POP-HT trial 03.12.2023 5:00
AHA23 Congress Coverage: BP control after hypertensive pregnancy (POP-HT)
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia 20.11.2023 3:13
AHA23 Congress Coverage: HTN and Dementia
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical AF: ARTESIA trial 20.11.2023 7:21
AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without DM: SELECT trial 20.11.2023 5:09
AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without DM or HF: DAPA-MI trial 20.11.2023 3:54
AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in MI and Anemia: MINT trial 20.11.2023 4:51
AHA23 Congress Coverage: Blood Transfusion in MI and Anemia (MINT trial)
Case Discussion 102: Diagnosis and management of Retroaortic Anomalous Coronary Artery 20.11.2023 6:56
Case Discussion 102: Retroaortic Anomalous Coronary Artery
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.